» Articles » PMID: 1365039

Muscle Morphometry in Amyotrophic Lateral Sclerosis

Overview
Journal Int J Neurosci
Publisher Informa Healthcare
Specialty Neurology
Date 1991 Jun 1
PMID 1365039
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Quadriceps muscle biopsies from 24 patients with amyotrophic lateral sclerosis (ALS) and 15 age-matched controls were prepared for histochemistry and analyzed morphometrically. Pathological features for denervation and reinnervation were observed in most ALS patients, although considerable variation between patients was noted. Myopathic changes were also seen in one-third of the cases. The morphometric data were not only related to the duration and mean diameter of type I fiber, but also to the duration and hypertrophy factor of type II fiber, suggesting that the progression and severity of ALS depends on the preservation of both fibers.

Citing Articles

Therapeutics Targeting Skeletal Muscle in Amyotrophic Lateral Sclerosis.

Gao J, Sterling E, Hankin R, Sikal A, Yao Y Biomolecules. 2024; 14(7).

PMID: 39062592 PMC: 11275039. DOI: 10.3390/biom14070878.


Skeletal muscle dysfunction in amyotrophic lateral sclerosis: a mitochondrial perspective and therapeutic approaches.

Kubat G, Picone P Neurol Sci. 2024; 45(9):4121-4131.

PMID: 38676818 PMC: 11306305. DOI: 10.1007/s10072-024-07508-6.


Statins block mammalian target of rapamycin pathway: a possible novel therapeutic strategy for inflammatory, malignant and neurodegenerative diseases.

Lashgari N, Roudsari N, Tamehri Zadeh S, Momtaz S, Abbasifard M, Reiner Z Inflammopharmacology. 2022; 31(1):57-75.

PMID: 36574095 PMC: 9792946. DOI: 10.1007/s10787-022-01077-w.


Treatment with Herbal Formula Extract in the hSOD1 Mouse Model Attenuates Muscle and Spinal Cord Dysfunction via Anti-Inflammation.

Yang E, Lee S, Cai M Mediators Inflamm. 2022; 2022:4754732.

PMID: 35832305 PMC: 9273397. DOI: 10.1155/2022/4754732.


The Skeletal Muscle Emerges as a New Disease Target in Amyotrophic Lateral Sclerosis.

Pikatza-Menoio O, Elicegui A, Bengoetxea X, Naldaiz-Gastesi N, de Munain A, Gerenu G J Pers Med. 2021; 11(7).

PMID: 34357138 PMC: 8307751. DOI: 10.3390/jpm11070671.